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Abstract 
Introduction
Stroke is a major burden on the health system due to high fatality and major disability in survivors. Whilst Stroke incidence has 
declined in the developed world, it continues to increase in developing nations, including the MENA (Middle East and North 
Africa) region. This may reflect different risk factors and strategies to treat and manage patients prior to and after Stroke. 
Methods
We have conducted a systematic review of the prevalence, incidence and mortality of Stroke in the 23 countries of MENA region 
following the PRISMA guidelines. 
Results
8,874 published papers were retrieved through both PubMed and Embase. Of those, 38 studies were found to be eligible for 
inclusion in this review. Only thirteen countries in the MENA region had data points for the critical stroke parameters. Of these 
qualified studies, 14 were prospective, population-based studies. In the age-adjusted studies, incidence ranged widely between 
16/100,000 in a prospective population-based in Iran to 162/100,000 in Libya. Age-adjusted prevalence was available only from 
Tunisia at 184/100,000. Mortality for all strokes from the eight countries reporting this measure found the 30-day-case fatality 
ranged from 9.3% in Qatar to 30% in Pakistan.Most stroke studies in the MENA region were small sized, hospital-based, lacked 
confidence intervals and did not provide prevalence and mortality figures.
Conclusion
National policymakers, public health and medical care stakeholders need more reliable epidemiologic studies on Stroke from the 
MENA region to plan more effective preventive and therapeutic strategies.
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Abbreviations
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Introduction
Stroke is a major burden on health systems due to high fatal-
ity rates and major disability in survivors [1]. Despite a decline 
in stroke incidence in the developed world, developing nations 
are witnessing a growing problem [2]. Indeed, over 80% of all 
stroke deaths in the world occur in developing countries. This in-
cludes the MENA (Middle East and North Africa) region, which 
includes heavily populated and lesser-developed countries as 
well as more developed countries with varied ethnic groups 
from South Asia and South-east Asia [3,4].
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Studies have shown that different ethnic groups have different 
lifestyle, demographic, and/or socioeconomic factors and resul-
tant epidemiological patterns and outcomes of stroke. The ability 
to deliver effective strategies to prevent and manage stroke can 
impact significantly on morbidity and mortality in stroke [5-7].
Since stroke prognosis, risk factor management and treat-
ment strategies differ when stroke incidence, prevalence and 
mortality in populations are considered, we undertook a system-
atic review of studies on stroke in the MENA region.
Methods
Data sources and search strategy
We conducted a systematic review of the prevalence and 
incidence of Stroke in the 23 countries of MENA region (Su-
dan, Somalia, Djibouti, Pakistan, Afghanistan, Algeria, Bahrain, 
Egypt, Jordan, Kuwait, Lebanon, Libya, Iran, Iraq, Morocco, 
Oman, Qatar, Saudi Arabia, Syria, Tunisia, United Arab Emir-
ates, Palestine and Yemen) (Figure 1). The review was conduct-
ed following the PRISMA guidelines and the PRISMA checklist 
can be found in Supporting Information [8]. Our search criteria 
and methods can be delineated in Figures (2). Briefly, PubMed 
and EMBASE databases were used for this review. The data-
bases were searched using text terms and MeSH/Emtree terms 
exploded to cover all sub-headings, encompassing 30 years be-
tween 1985 and 2016. We used a broad search criterion with no 
restrictions for language, or year of publication. 
Study selection
The search results were imported to a reference manager, End-
note, and screened for duplicate papers. After exclusion of du-
plicates the titles and abstracts of the final set of distinctive pa-
pers was exported to Microsoft Excel. All the extracted articles 
were screened for relevance by four authors (HG, AM, SA and 
DD). The process of screening was conducted in two separate 
steps: First level of screening involved screening titles and ab-
stracts of all papers to exclude all non-relevant articles; second 
level involved screening the full-text of all relevant or poten-
tially relevant articles thus, excluding all non-eligible articles. 
Since the review extend over several years (2013-17) two pairs 
of reviewers were involved. In each case, after the both authors 
screened the articles, the excluded papers were reviewed by the 
opposite author. Thus, insuring that no eligible article is lost. 
Discrepancies were settled by the lead author (LJS). Any paper 
reporting the incidence or prevalence of stroke based on primary 
data were included in this review. For additional sources of data, 
the authors checked the reference lists of included articles and 
identified publications to supplement our searches. All forms of 
study designs except literature reviews, case reports, case series 
editorials, and letters to editors were included in the review. A 
publication is included in the review if it had a data point on 
either the prevalence of any type strokes, or the incidence of any 
type of stroke, or both. 
Data extraction and data synthesis
Data from relevant articles was extracted primarily by four 
authors, HG, AM, SA and DD, for the following indicators: au-
thor, year of publication, year of study, country of study, study 
design, sampling technique, population, sample size, stroke in-
cidence and stroke prevalence. Stroke parameter of incidence 
and prevalence were generally expressed as 100,000 popula-
tion (persons) per year. We made no note of the mix of ethnici-
ty or immigration status of the populations cited in our review. 
Though the articles were not search for mortality and risk fac-
tors, this information was extracted from relevant reports when 
available. Data was extracted from abstracts when the full text 
was unavailable. Author DD screened any studies in Arabic or 
French. The schematic of the study selection process was adapt-
Figure 1: Map of the MENA region involved in this systematic review of Stroke in the MENA region. Figure courtesy of Prof. Abu Raddad and 
author on this review.
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Figure 2: Search string text schema used in this systematic review.
ed from the PRISMA 2009 flow diagram [8]. 
Results
Search Summary
We retrieved 8,874 published papers through both PubMed 
and Embase databases as of January 25, 2014. We excluded 
1,724 duplicate records from the retrieved set of papers. After 
screening the titles and abstracts of the 7,150 unique studies, 
the full-text of 211 potentially relevant papers were retrieved for 
screening. In December 2016, the databases were re-searched to 
included more current publications, yielding 60 additional possi-
bly eligible papers. After exclusion of 138 studies following full 
text review, 38papers were found eligible for inclusion in this 
review (Figure 3). 
Stroke Parameters Overview
Twenty-four data points were extracted on the incidence 
of stroke from the relevant records, and presented in Table (1). 
Of these studies, six were prospective hospital based incidence 
studies, and only three of those studies reported age-adjusted 
data on incidence of acute stroke. The crude incidence of stroke 
reporting both ischemic and hemorrhagic stroke ranged between 
9/100,000 in a prospective population-based study from Iran to 
640/100,000 in retrospective hospital-based study in Pakistan. In 
the age-adjusted studies incidence ranged between 16/100,000 in 
a prospective population-based study from Iran to 196/100,000 
in a prospective population-based study in Libya.
Data on the prevalence of stroke was extracted from the 38 
relevant studies and we found only seven data points for this 
parameter. Age-adjusted prevalence was available only from Tu-
nisia at 184/100,000.
Mortality data points were reported in eight of the relevant 
studies. Of the eight countries reporting mortality data, the 
30-day-case fatality ranged between 9.3% in Qatar to 30% for 
Pakistan. The studies that reported only ischemic stroke sub-
types had much lower mortality rate, ranging from 7% to 24% 
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in Iran. Conversely, series reporting only hemorrhagic stroke 
(ICH) had the highest mortality as in a Jordanian report of 42% 
mortality for spontaneous ICH.
Risk factors were systematically studied and identified in all 
13 countries reporting stroke incidence, prevalence or mortali-
ty. In 26 of the relevant countries, hypertension was the leading 
risk factor identified followed closely by diabetes and rheumatic 
valvular disease. Considering all studies, over two-thirds of in-
dividuals presenting with ischemic or hemorrhagic stroke were 
hypertensive.
The following is our synthesis stroke incidence, prevalence 
and mortality from each of the MENA region countries from 
which relevant epidemiologic stroke data was extracted 
(Table 1).
Review of Stroke Incidence, Prevalence and Mortality by 
Country
Bahrain: A retrospective hospital based study in 2000 by 
Al-Jishet al. at the Salmaniya Medical Complex, Bahrain, re-
ports a crude stroke incidence of 57/100,000. The incidence is 
higher in males as compared to females in all age groups. Hy-
pertension, dyslipidemia, diabetes mellitus, ischemic heart dis-
ease and smoking were commonly identified risk factors [9]. In 
a retrospective study of 872,288 individuals in 2015, Al Bannaet 
al. reported a crude stroke incidence of 60/100,000, with diabe-
tes, hypertension and dyslipidemia being the most common risk 
factors for stroke [10].
Egypt: A prospective, population based study conducted in 
Assiut Governorate, Egypt by Khedr et al., in 2013 reported a 
crude stroke prevalence of 963/100,000 and an age-adjusted 
stroke prevalence of 699.2/100,000. The male to female ratio 
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Figure 3: PRISMA flow diagram of search conducted in systematic review of Stroke in the MENA region.
 
*Reasons for exclusion: 
• Full-text did not include data on relevant indicators (n= 253) 
• Article is an editorial/commentary/letter to editor (n=4) 
• Full-text could not be retrieved and abstract does not have data on relevant outcomes (n=15) 
• Same dataset as another included relevant publication (n=5) 
• Paper presents contradictory/unclear numbers that could not be verified (n=0)  
Citation
Year 
of 
Data 
Col-
lec-
tion
Study Design Population
Sam-
ple 
Size
Stroke Incidence 
(per 100,000 
pop./yr.)
Stroke Prev-
alence (per 
100,000 pop./
yr)
Stroke 
Mortal-
ity
Bahrain (n=2)
A. A. Al-Jish, et 
al., 2000 [9]
1995 Retrospective Hospital-based 144 57/100,000 NA NA
M. Al Banna, et 
al., 2015 [10]
2011 Retrospective Hospital based 872288 60/100,000 crude NA NA
Egypt (n=6)
E. M. Khedr, et al., 
2013 [11]
2010 Prospective
Popultion
based Assuit
5920 _ 963/100,000 NA
E. M. Khedr, et al., 
2014 [15]
2011-
2013
Retrospective
Population 
based - Qena
8027 137/100.000 crude 797/100000 NA
H. N. El-Tallawy, 
et al., 2013 [13]
2009-
2012
Prospective
Popultion 
based
19848 181/100,000 655/100,000 NA
W. M. A. Farghaly, 
et al., 2013 [14]
2005-
2008
Prospective
Popultion 
based
62583 250/100000 560/100,000 NA
H. N. El Tallawy, 
et al., 2010 [15]
2005-
2009
Prospective
Popultion 
based
62583 250/100,000 NA NA
H. N. El Tallawy, 
et al., 2015 [16]
2006-
2012
Retrospective
Population 
based
447 - 7.2/1000 NA
Jordan (n=1)
Y. G. Bahou, et al., 
2009 [17]
2002-
2007
Retrospective
Hospital-based 
- Amman
1498 15.8/100,000 NA
All 
strokes 
= 42.0%
Iran (n=11)
M. Azarpazhooh, 
et al., 2013 [18]
2007-
2008
Prospective
Popultion
based
92974
16/100,000 crude 
13/100,000 (CL: 
9-17) age-adjusted
- NA
M. R. 
Azarpazhooh, et 
al., 2010 [19]
2006-
2006 Prospective
Population 
based 450229 139/100000 crude
NA NA
Table 1: Studies reporting Stroke incidence or prevalence in the MENA region
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M. Tohidi, et al., 
2013 [20]
1999-
2001 Prospective
Hospital-based 
Tehran 2620 326/100,000
NA NA
A. Ahangar, et al., 
2005 [21]
2001-
2003 Prospective
Hospital based 
Babol 550,00 52/100,000 crude
NA
All 
strokes 
= 19.2%
N. Fahimfar, et al., 
2012 [22]
1999-
2009 Prospective
Popula-
tion-based 2378
M450/100,00(CL: 
330-600) & W 
25/100,000(CL: 
170-360)  -
NA
N. Sarrafzadegan, 
et al., 2011 [23] 2001 Longitudinal
Popula-
tion-based 
Isfahan 24379 230/100,000
NA NA
S. Zabihyan, et al., 
2011 [24]
2008-
2009 Retrospective Hospital-based 143
1.3/100,000 (SAH 
only)
NA NA
A. Delbari, et al., 
2011 [25]
2006-
2008 Prospective Hospital-based 953
338/100,000 (Age 
> 45yrs.)
NA IS = 
15.3%
M. D. Firoozabadi 
et al., 2013 [26]
2002-
2008 Prospective Hospital-based 1219
48.6-
103.4/100,000, 
yr. 1-6
NA
IS = 
13.0% 
ICH = 
23.0%
K. Ghandehari, et 
al., 2006 [27]
2001-
2005 Prospective Hospital-based 1392 43.2/100,000
NA IS = 
7.3%
S.Oveisgharan, et 
al., 2017 [28]
2000-
2003 Prospective Hospital based 4361 73.4/100000 crude
NA NA
Kuwait (n=2)
A. Ashkanani, et 
al., 2013 [29] 2008 Retrospective Hospital-based 151 27.6/100,000
NA
NA
N. Abdul-Ghaffar, 
et al., 1997 [30]
1989-
1993 Prospective Hospital-based 241
27.9/100,000 
(CL:27.5-
27,6) crude 
92.2/100,000 (CL: 
69.6-114.) age-ad-
justed
NA
All 
strokes 
= 10.0%
Lebanon (n=2)
R. Farah, et al., 
2015 [31] 2014 Prospective 
Population 
based 15155 NA
3630/100,000
NA
N. Lahoud, et al., 
2015 [32] 2012 Retrospective
Population 
based 6963 NA
500/100,000 
age- adjusted 
prevalence 
NA
Libya (n=2)
S. El Zunni, et al., 
1995 [33]
1991-
1993 Retrospective Hospital-based 921
48/100,000 crude 
162/100,000 
age-adjusted NA NA
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P.P. Ashok, et al., 
1986 [34]
1984-
1986 Prospective
Population 
based 518745 63/100000 crude NA NA
Pakistan (n=3)
A. K. Kamal, et 
al., 2009 [35]
2008-
2009 Prospective
Popultion based 
- BialColony, 
Karachi 545 NA
19000/100,000 
(CL: 18.4-25.5) NA
T. H. Jafar, et al., 
2006 [36]
2001-
2002 Prospective
Population 
-based 500 NA 4800/100,000 NA
E. A. Vohra, et al., 
2000 [37]
1982-
1990 Retrospective Hospital-based 12454 6/100,000 NA
All 
strokes 
= 30%
Palestine (n=1)
W. M. Sweileh, et 
al., 2008 [38]
2006-
2007 Prospective Hospital-based 186
51.4/100,000 (CL: 
44-58.8)
62.7/100,000 
(CL: 51.1-74.4)
All 
strokes 
= 21%
Qatar (n=3)
A. Hamad, et al., 
2001 [39]
1997-
1997 Prospective
Hospital-based- 
Doha 217
41/100,000 (CL: 
30.2 – 52.4), 
123.7/100,000 
(CL: 103.0-144.3) 
age-adjusted NA NA
Abdulbari Bener, 
et al., 2006 [40]
1999-
2003 Prospective Hospital-based 377 11.8/100,000 NA NA
F. Ibrahim, et al., 
2015 [41]
1990-
2015 Retrospective
Population 
based 1491 51.88/100,000 NA
All 
strokes 
= 9.3%
Saudi Arabia (n=3)
A. E. Ayoola, et 
al., 2003 [42]
1997-
1998 Retrospective
Hospital-based- 
Gizan 241 15.1/100,000 NA NA
S. Al Rajeh, 
1998[43]
1989-
1993 Prospective
Popula-
tion-based- 
Eastern prov-
inces 488
29.8/100,000 
(CL: 25.2-34.4), 
38.5/100,000 
age-adjusted NA
Al 
Strokes 
= 15%
S. Al Rajeh, 1993 
[44]
1982-
1992 Retrospective
Hospital-based- 
Riyadh 500 43.8/100,000 186/100,000 NA
Syria (n=1)
W. Maziak, 2007 
[45] 2004 Prospective
Popula-
tion-based- 
Aleppo 2038 NA 1008/100,000 NA
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in the region was reported to be approximately 1.7:1 and hy-
pertension and diabetes were the most common risk factors 
for strok [11]. Another prospective, population based study in 
Al Kharga district, New valley, Egypt by El Tallawy et al., in 
2010 reported a prevalence of 560/100,000 in the population 
>18 years and an incidence of 250/100,000 [12]. Another pro-
spective population-based study conducted by El Tallawy et al., 
in Al Quseir city reported a prevalence of 655/100,000 and an 
incidence 181/100,000, with a higher prevalence in males and 
with increasing age [13]. Moreover, a retrospective study in 
2014 by Khedr et al., reported an incidence of 137/100,000 and 
a prevalence of 797/100,000 for stroke, in Qena [12-15]. The 
most recent study by El Tallawy et al., in 2015, reported a stroke 
incidence of 7.2/100,00 with the most common risk factors be-
ing hypertension, hyperlipidemia and diabetes [16].
Iran: Iran stands out in the MENA region with the most prolific 
research on the incidence of stroke with four population-based 
and seven hospital-based studies. However, there are no data on 
the prevalence of stroke in Iran. Azarpazhooh et al., has published 
two population-based studies; the most recent one was a prospec-
tive study on the incidence of stroke in Hajj pilgrims, yielding an 
age-adjusted incidence of 7/100,000 [17-19]. The second study 
is a large population based study of 450,229 people from Mash-
had, and reported a crude age-adjusted incidence of 13/100,000 
[18]. In 2011, Sarrafzadegan et al., undertook a population-based 
study in Isfahan and reported an incidence of 230/100,000 [20-
23]. Fahimfar et al., undertook a population-based study in 2378 
participants and reported an incidence of 450/100,000 in males 
and 250/100,000 in females [22]. In a prospective hospital based 
study from 2005, Ahangar et al., reported a crude stroke inci-
dence of 52/100,000 with a stroke mortality of 19.2% [21]. In 
a hospital based retrospective study, Zabihyan reported an in-
cidence of 1.3/100,000 for sub-arachnoid haemorrhage [24]. In 
2013, Tohidi et al., reported an incidence of 326/100,000, in a 
small prospective hospital-based study of 2620 subjects [20]. A 
hospital-based prospective study by Ghandebari et al., in 2006 
reported a stroke incidence of 43.17/100,000 and a mortality of 
7.3% for ischemic stroke in Khorasan and noted that rheumatic 
valvular disease was the most common cause of ischemic stroke 
in young adults [25-27]. In 2013, Firoozabadi et al., reported 
an annual incidence of stroke ranging from 48.6-103.4/100,000 
with an overall in-hospital mortality of 17.1% and a mortality 
of 13% and 23% for ischemic stroke and intracranial haemor-
rhage, respectively. The most common risk factors for stroke 
were hypertension, cardiac diseases, history of stroke, diabetes, 
dyslipidemia and smoking [26]. Furthermore, Delbari et al., un-
dertook a cross sectional hospital based study in the Qom region 
with a sample size of 460, and reported an annual incidence of 
53/100,000, with a mortality of 15.3% for ischemic stroke [25]. 
The most recent study is by Oveisgharan et al., from 2016 and is 
a prospective hospital-based study which reported a crude stroke 
incidence of 73.4/100,000 [28]. 
Jordan: There is only one hospital based retrospective study 
from Amman by Bahou et al., undertaken in 2009 and report-
ed a haemorrhagic stroke incidence of 15.8/100,000 with an all 
stroke mortality of 42% [17]. 
Kuwait: A prospective, hospital-based study from Adan Hospi-
tal has reported a crude stroke incidence of 27.6/100,000, with 
an age-adjusted stroke incidence of 145.6/100,000 and a 30-
day case fatality of 10%. Hypertension, diabetes, heart disease, 
smoking and hypercholesterolemia were the most common risk 
factors for stroke [29,30]. In 2013, a hospital-based retrospec-
tive study by Ashkanani et al., reported a stroke incidence of 
27.6/100,000.
Lebanon: In 2015, a population-based prospective study by Far-
ah et al., reported a surprisingly high prevalence of 3630/100,000, 
with hypertension, history of heart disease and smoking as risk 
factors [31]. In support of this a retrospective population based 
study by Lahoud et al., in the same year also reported an age-ad-
justed prevalence of 500/100,000 [32].
Libya: A retrospective, hospital-based study from Beng-
hazi has reported a crude stroke incidence rate of 48/100,000 
and an age-adjusted stroke incidence rate of 162/100,000 and 
133/100,000 for males and females >45 years of age, respec-
tively. Hypertension, smoking, diabetes and cardiac lesions were 
identified as risk factors. In younger patient’s aged 15-45 years 
the annual incidence rate of stroke was 14/100,000 with hyper-
tension, diabetes and heart disease being identified as import-
ant risk factors [33]. In a 1986, prospective population based 
study from Benghazi, Radakrishnan et al., reported a crude 
stroke incidence of 63/100,000 with a crude incidence rate of 
39.3/100,00 and 40.3/100,000, respectively and age adjusted 
rates of 47.7/100,000 and 46.1/100,000, for men and women, 
respectively. Hypertension was the most common risk factor and 
was present in 45% of patients, followed by diabetes mellitus 
and rheumatic valvular disease, with at least one risk factor pres-
Tunisia (n=1)
N.A. Romdhane, 
1993 [46] 1985 Prospective
Popula-
tion-based- Ke-
libia 35370 NA
120/100,000 
crude, 
184/100,000 
age-adjusted NA
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ent in 78% of patients [34].
Pakistan: A prospective population-based study of 545 sub-
jects in Karachi an exceptionally high incidence of stroke of 
19,000/100,000 was reported [35]. In contrast an earlier pro-
spective population based study by Jafar with a sample size of 
500 reported an incidence rate of 4800/100,000 in Karachi [36]. 
Vohra et al., undertook a retrospective hospital based study in 
12454 subjects and reported a stroke incidence of 640/100,000, 
with an overall stroke morbidity of 30%. Hypertension, cardiac 
disease, diabetes, history of previous stroke and smoking were 
the most common risk factors for stroke in this study [37].
Palestine: A prospective hospital-based by Sweileh et al., in 
2008 with a population size of 186 was conducted between the 
years 2006-2007 and the study reported a crude incidence of 
51.4/100,000 (CL: 44-58.8). The age-adjusted incidence was 
calculated to be 89.8/100,00 age adjusted. Mortality was 21% in 
all stroke types. Hypertension, diabetes mellitus and renal dys-
function were the most common risk factor in the patients [38].
Qatar: In a study of prospective and retrospective outcomes un-
dertaken in 1999-2003, Bener et al., reported an incidence of 
11.7/100,000. There was a strong association with hypertension 
and diabetes with 60% of the stroke patients having had a previ-
ous acute myocardial infarction and 46.4% had diabetes mellitus 
[39,40]. In a prospective hospital-based study from 1997, Ha-
mad et al., reported a somewhat higher incidence of 47/100,000 
with an overall stroke mortality of 16% [39]. Ibrahim in 2015, 
undertook a retrospective population based study and reported a 
stroke incidence of 51.8/100,000 and a 30-day stroke mortality 
of 9.3% [41].
Saudi Arabia: A retrospective hospital based study in King Fa-
had National Guard Hospital reported a crude stroke incidence 
rate of 43.8/100,000 and hypertension, diabetes mellitus, and 
heart disease were common risk factors, smoking was iden-
tified as a less common risk factor in this population [42-44]. 
Another hospital-based retrospective study from Gizan was 
undertaken by Ayoola et al., and reported a stroke incidence of 
15.1/100,000 [42]. In 1998, a population-based study from the 
Eastern provinces by Al Rajeh et al., reported a stroke incidence 
of 29.8/100,000 and an age-adjusted incidence of 38.5/100,000; 
with a stroke mortality of 15%. Hypertension, diabetes, heart 
disease, smoking and a previous stroke were the most significant 
risk factors for stroke [43].
Syria: In a prospective population based study in Aleppo, the 
prevalence of stroke in adults aged 18 to 65 years old was 
1000/100,000 and hypertension, obesity and smoking were iden-
tified as the most common risk factors [45].
Tunisia: A prospective population-based study by Romdhane 
et al., in 1993 in Kelibia, Tunisia reported a crude prevalence 
of 120/100,000, and an age-adjusted prevalence of 184/100,000 
[46].
Discussion 
Stroke is a major global health problem, particularly in the 
MENA region due to an aging population and multi-ethnic expa-
triate population with disparate availability and delivery of health 
care [2,47]. To gain an overview of the scope of the problem and 
deficiencies of studies in the MENA region, we have completed 
a systematic review specifically assessing the availability of ep-
idemiologic data on stroke incidence, prevalence and mortality. 
Our review has focused on the MENA region where there is a 
predominance of developing countries apart from four gulf na-
tions (Bahrain, Kuwait, Qatar and Saudi Arabia).
The review for the region was published in 2010, but was 
derived from data collected between 1983 and 2007 and was 
only from seven countries. After age-standardization it revealed 
a wide range of stroke incidence ranging from 38.5/100,000 in 
Saudi Arabia to 123.7/100,000, in Qatar [3]. This supports the 
contention of Feigin et al. (2009), which suggests that stroke 
incidence rates in the MENA region are lower than other parts 
of the world [48]. Benamer (2014) concluded that the incidence 
of both age adjusted and unadjusted incidence of stroke was 
lower in the MENA region compared to developed countries 
and attributed it to the fact that many of the studies were ei-
ther hospital based or were population based and suffered from 
sampling errors [49]. Indeed, none of the studies from the sev-
en Arab countries in the Middle East (ME) he cited, fulfilled 
the strict criteria of an ideal epidemiological study proposed by 
Sudlow and Warlow (1996) and utilized by Feigin (2004) [7]. In 
fact, no Arab countries were included in the systematic review 
of worldwide stroke incidence from 1970-2008 by Feigin and 
co-workers (2009) [48].
A great deal of weight is being given to the Global and Re-
gional Burden of Stroke (1990-2013) which has revealed diver-
gent data on some stroke mortality and disability between devel-
oped (high-income) and developing (low-and middle-income) 
countries [1]. It suggests that certain regions of the world have 
a disproportionate increased burden of stroke. Our review has 
focused on the MENA region where there is a predominance 
of developing countries. No relevant stroke research papers 
were found from low-income MENA countries. With exception 
of four high-income, Gulf nations (Bahrain, Kuwait, Qatar and 
Saudi Arabia), relevant papers were from nine middle income 
MENA countries. All papers would be considered developing 
countries. Indeed, studies including longitudinal data on stroke 
incidence show increasing trends for this parameter [23,41]. 
Unfortunately, no comparative mortality or disability data was 
included in these papers. Nevertheless, these observations sup-
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port the contention of there is a divergence between developed 
and developing countries regarding stroke incidence trends over 
the past four decades with reduction in developed countries and 
increase in developing countries [48].
As observed by prior epidemiologic researchers, MENA 
region reports prior to 2014 found a predominance of small 
samplings from predominantly hospital-based studies for the 
region providing the basis for estimates of stroke incidence and 
the outstandingly low figures for several of the middle eastern 
gulf countries, particularly Qatar and Kuwait [2]. Our qualita-
tive analysis of the crude incidence and age-adjusted prevalence 
in population-based reports between 1995 and 2016, including 
the Gulf region, has also found figures lower than most devel-
oped countries (America and Western Europe). This arose from 
low numbers of stroke research publications fulfilling our search 
criteria. Stroke incidence was biased by small sample sizes, pre-
dominant hospital-based studies and lax epidemiological meth-
odology with mainly observational statistics lacking Confidence 
Intervals. Stroke prevalence data was found for seven MENA 
countries with only one age-adjusted, population-based report 
from 1985 meeting inclusion criteria [46]. 
In a recent review by El-Hajj and colleagues, 64 papers from 
nine Middle Eastern countries were reviewed and analyzed them 
for their epidemiologic value including the parameters shared 
with our study, including incidence, prevalence and case fatality 
[50]. They noted the same difficulties in their attempt to syn-
thesize very heterogeneous studies. As we have remarked, the 
studies found were marked by relative lack of community or 
population-based acquisition; small sample size; lack of age-ad-
justment and prospective design. 
In relation to risk factors for stroke, hypertension was the 
most prevalent risk factor, followed by diabetes, dyslipidemia 
and cardiac diseases. This simply reflects the huge increase in 
obesity and associated cardiometabolic risk factors in the MENA 
region [51]. Additionally, recent data from 1491 stroke patients 
in the Qatar Stroke registry show that 50% of stroke patients are 
aged less than 50 years [41].
There is an obvious need for nationwide coordinated ef-
forts from government and community to prevent and treat 
stroke through research and implementation of modern stroke 
care planning and registries. Fundamentally, stroke research 
should include well-designed epidemiologic studies of the true 
incidence, prevalence and case fatality for each of the MENA 
countries including those of low income. Considering the urgent 
need, this could very well take the form of enrollment in the 
WHO STEP wise approach to stroke surveillance [52]. This, to-
gether with community stroke education and stroke risk factor 
management, seems a rational approach to an alarming health 
problem. 
Conclusion
High quality stroke research in the MENA region must be-
come a national priority and appropriate infrastructure provided. 
As a first step, national policymakers, public health and medical 
care stakeholders need more reliable epidemiologic studies upon 
which to gauge the effectiveness of therapeutic and preventive 
measures targeting the growing burden of stroke in this region 
of the world.
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